Chiropractors in Soda Springs, ID Accepting Medicare
6 Chiropractors found. Showing 1 - 6
 Bowman Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 300 W 2nd S, Soda Springs, ID 83276 Phone: 208-547-4151 Fax: 208-547-4093 |
 Dr. Wesley Aaron Bowman, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 300 W 2nd S, Soda Springs, ID 83276 Phone: 208-547-4151 Fax: 208-547-4093 |
Bowman Chiropractic Pllc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 300 W 2nd S, Soda Springs, ID 83276 Phone: 208-547-4151 Fax: 208-547-4093 |
Dr. Eric Bowman, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 300 W 2nd S, Soda Springs, ID 83276 Phone: 208-547-4151 Fax: 208-547-4093 |
Dr. Jared Mark Shelton, DC, BS, CSCS Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 45 W Center St, Soda Springs, ID 83276 Phone: 208-547-4518 Fax: 208-547-4555 |
Bear River Chiropractic, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 45 W Center St, Soda Springs, ID 83276 Phone: 208-547-4518 Fax: 208-547-4555 |
News Archive
Oestrogen works for women the way testosterone does for men
Collaboration by American and German scientists has revealed that the sex hormone oestrogen increases a women's competitiveness.
Medicare officials signal no payment changes on anemia drugs
Medicare officials signaled Wednesday that they will not change a payment policy for biotech drugs made by Amgen and Johnson & Johnson when they are used to treat anemia in kidney disease patients, despite data suggesting heart risks for those patients.
UT Southwestern gets NCI grant to establish Heavy Ion Radiation Therapy Research Center in US
UT Southwestern Medical Center is leading a Texas consortium of researchers to establish the country's first National Center for Heavy Ion Radiation Therapy that could provide clinical care and research using heavy particles for innovative new cancer treatments.
Breckenridge acquires Cypress Pharmaceutical product assets from Pernix Therapeutics
Breckenridge Pharmaceutical, Inc. announced today that it has completed its acquisition of certain Cypress Pharmaceutical, Inc. product assets from Pernix Therapeutics. The assets include 11 Abbreviated New Drug Applications filed with the FDA, certain ANDAs in various stages of development, as well as 6 already-approved and marketed products.
› Verified 1 days ago